CORAUTUS GENETICS INC 4
4 · CORAUTUS GENETICS INC · Filed Jun 7, 2007
Insider Transaction Report
Form 4
LARSON JOHN RANDOLPH
Director
Transactions
- Award
Stock Option (right to buy)
2007-06-05+5,575→ 20,957 totalExercise: $5.10From: 2007-06-05Exp: 2017-06-05→ Common Stock (5,575 underlying)
Footnotes (1)
- [F1]Reflects a 1-for-15 reverse stock split, which became effective on June 5, 2007. In connection with the merger of VIA Pharmaceuticals, Inc. with Corautus Genetics Inc. (the "Merger"), the 15,382 (on a reverse split adjusted basis) stock options held by Mr. Larson prior to the consummation of the Merger became immediately exercisable, and as a result, all 20,957 stock options held by Mr. Larson are exercisable.